ASNS - asparagine synthetase (glutamine-hydrolyzing) Gene
Species: Macaca mulatta
Gene Type: protein coding
Gene ID: 697232
ASNS Products (6)
| mRNA | Protein | Name |
|---|---|---|
| XM_015134310.2 | XP_014989796.2 | asparagine synthetase [glutamine-hydrolyzing] |
| XM_001089407.4 | XP_001089407.2 | asparagine synthetase [glutamine-hydrolyzing] |
| XM_001089182.4 | XP_001089182.2 | asparagine synthetase [glutamine-hydrolyzing] |
| XM_028846040.1 | XP_028701873.1 | asparagine synthetase [glutamine-hydrolyzing] |
| XM_015134307.2 | XP_014989793.2 | asparagine synthetase [glutamine-hydrolyzing] |
| XM_015134308.2 | XP_014989794.2 | asparagine synthetase [glutamine-hydrolyzing] |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
asparagine synthetase [glutamine-hydrolyzing] |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(7)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-132254 | Sacituzumab govitecan | Inhibitor | 99.13% | Unkown |
| HY-132254A | Sacituzumab govitecan (solution) | Inhibitor | 99.19% | Unkown |
| HY-N0667 | L-Asparagine | 99.78% | Unkown | |
| HY-W017443 | L-Asparagine monohydrate | 99.77% | Unkown | |
| HY-14874 | Topiroxostat | Inhibitor | 99.06% | Unkown |
| HY-123319 | Antofloxacin hydrochloride | Inhibitor | / | Unkown |
| HY-123319A | Antofloxacin | Inhibitor | / | Unkown |
Clinical Phase
Bioactive Molecules
(5)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-103018 | Gusacitinib | Inhibitor | 99.63% | Phase 2 |
| HY-103018A | Gusacitinib hydrochloride | Inhibitor | / | Phase 2 |
| HY-136579 | ASN007 | Inhibitor | 99.48% | Phase 1 |
| HY-160196 | HC-7366 | Inhibitor | 99.58% | Phase 1 |
| HY-136579A | ASN007 benzenesulfonate | Inhibitor | 99.72% | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(127)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-128946 | CL2A-SN-38 | 99.97% | Unkown | |
| HY-128923 | SKF-34288 hydrochloride | Inhibitor | 98.61% | Unkown |
| HY-136626 | Z-Ala-Ala-Asn-AMC | 99.28% | Unkown | |
| HY-W002327 | Fmoc-Asn(Trt)-OH | 99.96% | Unkown | |
| HY-108625 | SHA 68 | Antagonist | 99.84% | Unkown |
| HY-112205A | RR-11a analog | Inhibitor | 99.12% | Unkown |
| HY-164668 | ADC Control Human IgG1-SN-38 | 97.53% | Unkown | |
| HY-N0667S2 | L-Asparagine-15N2 monohydrate | 99.95% | Unkown | |
| HY-P4385 | (Asn10,Leu11,D-Trp12)-pTH-Related Protein (7-34) amide (human, mouse, rat) | Antagonist | 99.77% | Unkown |
| HY-139147 | iHCK-37 | Inhibitor | 99.52% | Unkown |
| HY-175282 | ASX-173 | 98.47% | Unkown | |
| HY-114174 | Fmoc-Ala-Glu-Asn-Lys-NH2 | 99.55% | Unkown | |
| HY-W010378 | D-Asparagine | 98.0% | Unkown | |
| HY-156586 | Egalognastat | Inhibitor | 99.03% | Unkown |
| HY-N9446 | H-Asn(glcnac-beta-D)-OH | 98.65% | Unkown | |
| HY-P1341 | OXA(17-33) | 97.48% | Unkown | |
| HY-P1043A | NGR peptide Trifluoroacetate | 98.91% | Unkown | |
| HY-N0667S3 | L-Asparagine-13C4 monohydrate | 98.9% | Unkown | |
| HY-W009085 | Fmoc-Asn-OH | 99.19% | Unkown | |
| HY-111323 | ASN06917370 | 99.23% | Unkown | |
| HY-W017443S | L-Asparagine-13C4,15N2 monohydrate | 98.0% | Unkown | |
| HY-128111 | ASN02563583 | Activator | 99.21% | Unkown |
| HY-B1803A | Tracazolate hydrochloride | Modulator | 99.24% | Unkown |
| HY-E70068 | Endo-β-N-acetylglucosaminidase (Endo S) | / | Unkown | |
| HY-N0667S5 | L-Asparagine-d3 hydrate | 99.64% | Unkown | |
| HY-148393 | G0 N-glycan-Asn | 99.95% | Unkown | |
| HY-113667 | ASN04885796 | Activator | 99.61% | Unkown |
| HY-P11200 | γ-Glu-Asn | 98.12% | Unkown | |
| HY-W013330 | 3′-Deoxyguanosine | 97.0% | Unkown | |
| HY-P4279 | Ovalbumin (154-159) | Inhibitor | 99.18% | Unkown |
| HY-125028 | Hck-IN-1 | Inhibitor | 98.10% | Unkown |
| HY-150242A | Cbz-Ala-Ala-Asn TFA | 99.54% | Unkown | |
| HY-150579 | Keap1-Nrf2-IN-13 | Inhibitor | 96.77% | Unkown |
| HY-162238 | OSM-S-106 | Inhibitor | 99.34% | Unkown |
| HY-150787 | BMS-986339 | 99.74% | Unkown | |
| HY-128128 | ASN04421891 | Modulator | 99.00% | Unkown |
| HY-131092A | H-Asn-Arg-OH diTFA | 99.83% | Unkown | |
| HY-141464 | Fmoc-L-Asn(beta-D-GlcNAc(Ac)3)-OH | 95.03% | Unkown | |
| HY-175282A | (2S,3R,4S)-ASX-173 | Control | 99.29% | Unkown |
| HY-P10485 | Glp-Asn-Pro-AMC | 99.26% | Unkown | |
| HY-P1809A | Velmupressin acetate | Agonist | 99.47% | Unkown |
| HY-P1962 | β-Secretase inhibitor | Inhibitor | 98.06% | Unkown |
| HY-W010378R | D-Asparagine (Standard) | 99.90% | Unkown | |
| HY-129360A | Ala-Ala-Asn-PAB TFA | / | Unkown | |
| HY-156314 | ASN 07115873 | Inhibitor | 98.76% | Unkown |
| HY-172473 | DSPE-PEG2000-NGR | 95.0% | Unkown | |
| HY-176977 | Exatecan-mpGly-Asn-Asn-(βAla) | 96.25% | Unkown | |
| HY-180467 | Neu5Ac-2Galβ1-3Glc-oxazoline-(2)Me | / | Unkown | |
| HY-180467A | Neu5Ac-2Galβ1-3Glc-oxazoline-(2)Me sodium | / | Unkown | |
| HY-78162 | cis-3-Hydroxyproline | Substrate | 95.0% | Unkown |
| HY-N0667S | L-Asparagine-13C4,15N2,d8 | 99% | Unkown | |
| HY-N0667S1 | L-Asparagine-15N2,d8 | / | Unkown | |
| HY-P3882 | Fmoc-Ala-Glu-Gln-Lys-NH2 | 99.26% | Unkown | |
| HY-W008233 | Z-Asn-OH | 98.76% | Unkown | |
| HY-W017443S1 | L-Asparagine-amide-15N monohydrate | 99.80% | Unkown | |
| HY-148389 | Disialo-Asn | 98.04% | Unkown | |
| HY-W017443S2 | L-Asparagine-13C4,15N2,d3 monohydrate | 99.90% | Unkown | |
| HY-W142294 | Ac-D-Asn-OH | / | Unkown | |
| HY-P1809 | Velmupressin | Agonist | / | Unkown |
| HY-P1810 | c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-Agm | Agonist | / | Unkown |
| HY-P1043 | NGR peptide | 99.73% | Unkown | |
| HY-103018S | Gusacitinib-d4 | / | Unkown | |
| HY-113761 | ASN03576800 | Inhibitor | 99.61% | Unkown |
| HY-122179 | NUCC-555 | Antagonist | / | Unkown |
| HY-128947 | CL2 Linker | / | Unkown | |
| HY-129360 | Ala-Ala-Asn-PAB | / | Unkown | |
| HY-129361 | Fmoc-Ala-Ala-Asn-PABC-PNP | / | Unkown | |
| HY-130933 | Fmoc-Ala-Ala-Asn(Trt)-OH | 99.80% | Unkown | |
| HY-131463 | ASN-1377642 | Antagonist | / | Unkown |
| HY-136733 | Ac-DNLD-CHO | Inhibitor | / | Unkown |
| HY-139245 | MC-Ala-Ala-Asn-PAB | / | Unkown | |
| HY-141149 | Fmoc-PEG4-Ala-Ala-Asn-PAB | / | Unkown | |
| HY-141150 | Azido-PEG5-Ala-Ala-Asn-PAB | / | Unkown | |
| HY-141151 | Fmoc-PEG3-Ala-Ala-Asn(Trt)-PAB | / | Unkown | |
| HY-144628 | Fmoc-Asn-Pro-Val-PABC-PNP | 99.34% | Unkown | |
| HY-144629 | Asn-Pro-Val-PABC-MMAE TFA | / | Unkown | |
| HY-144630 | diSPhMC-Asn-Pro-Val-PABC-MMAE | / | Unkown | |
| HY-148031 | MC-Ala-Ala-Asn-PAB-PNP | / | Unkown | |
| HY-148392 | Neu5Gcα(2-6) N-Glycan-Asn | / | Unkown | |
| HY-149360 | P-gb-IN-1 | Inhibitor | / | Unkown |
| HY-149825 | MTHFD2-IN-1 | Inhibitor | / | Unkown |
| HY-149826 | MTHFD2-IN-2 | Inhibitor | / | Unkown |
| HY-149827 | MTHFD2-IN-3 | Inhibitor | / | Unkown |
| HY-149828 | MTHFD2-IN-4 | Inhibitor | / | Unkown |
| HY-149828A | MTHFD2-IN-4 sodium | Inhibitor | / | Unkown |
| HY-151146 | (1R,3S)-THCCA-Asn | Inhibitor | / | Unkown |
| HY-164457 | ASN-001 | Inhibitor | / | Unkown |
| HY-172472 | DSPE-PEG1000-NGR | / | Unkown | |
| HY-172473A | DSPE-PEG3400-NGR | / | Unkown | |
| HY-172474 | DSPE-PEG5000-NGR | / | Unkown | |
| HY-174223 | α-Glucosidase-IN-90 | Inhibitor | / | Unkown |
| HY-183362 | Antileishmanial agent-42 | Inhibitor | / | Unkown |
| HY-185461 | Mc-Asn-Asn-E104 | Agonist | / | Unkown |
| HY-185462 | Mc-Asn-Asn | / | Unkown | |
| HY-E71264 | β-Acetylglucosaminidase 18A, Bacteroides thetaiotaomicron | / | Unkown | |
| HY-N0667S4 | L-Asparagine-4-13C monohydrate | / | Unkown | |
| HY-N0667S7 | L-Asparagine-13C4,15N2 | / | Unkown | |
| HY-N15365 | Antcin B | Inhibitor | / | Unkown |
| HY-P11408 | [D-Cys6,Asn7,D-Ala11,Cys14]-Bombesin (6-14) | Agonist | / | Unkown |
| HY-P11620 | H-Asn-Pro-Glu-Tyr(PO3H2)-OH | / | Unkown | |
| HY-P1610 | Asudemotide | Inducer | / | Unkown |
| HY-P2212 | (Asn1,Val5)-Angiotensin II | / | Unkown | |
| HY-P2397 | Fmoc-Asn(Trt)-Thr(psi(Me,Me)pro)-OH | / | Unkown | |
| HY-P2401 | Fmoc-Asn(Trt)-Ser(psi(Me,Me)pro)-OH | / | Unkown | |
| HY-P3220 | [D-Asn5]-Oxytocin | Activator | / | Unkown |
| HY-P3615 | [Asn18] Endothelin-1 (swine, human) | Agonist | / | Unkown |
| HY-P3716 | H(-Asn-Pro-Asn-Ala)2-OH | / | Unkown | |
| HY-P4019 | Ac-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2 | / | Unkown | |
| HY-P4407 | (D-Asn28)-Exenatide | Control | / | Unkown |
| HY-P4919 | Mca-SEVNLDAEFK(Dnp) | / | Unkown | |
| HY-P5415 | DABCYL-GABA-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-EDANS | / | Unkown | |
| HY-RS01098 | ASNS Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W017443S3 | L-Asparagine-15N2,d3 monohydrate | / | Unkown | |
| HY-W017443S4 | L-Asparagine-1,2,3,4-13C4 monohydrate | / | Unkown | |
| HY-W091365 | Boc-Asn(Xan)-OH | / | Unkown | |
| HY-W845197 | L-Asparagine-15N2 | / | Unkown | |
| HY-118731 | TNK-6123 | Activator | / | Unkown |
| HY-129286 | ASN 05397535 | / | Unkown | |
| HY-131092 | H-Asn-Arg-OH | / | Unkown | |
| HY-141152 | Azido-PEG4-Ala-Ala-Asn(Trt)-PAB | / | Unkown | |
| HY-141153 | Fmoc-PEG3-Ala-Ala-Asn(Trt)-PAB-PNP | / | Unkown | |
| HY-151829 | Fmoc-L-Asn(EDA-N3)-OH | / | Unkown | |
| HY-157338 | NHS-Ala-Ala-Asn-active metabolite | Inhibitor | / | Unkown |
| HY-RS19117 | Asns Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS25607 | Asns Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W002327S | Fmoc-Asn(Trt)-OH-13C4,15N2 | 96.9% | Unkown | |
| HY-W173361 | CBP/p300-IN-24 | Inhibitor | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P992184 | Anti-5T4 scFv-Fc Antibody | / | Unkown | |
| HY-P991497 | ASN-500 | Inhibitor | / | Unkown |